Introduction
Gestational diabetes, scientifically referred to as gestational diabetes mellitus (GDM), is a prevalent medical condition that manifests in women who have not previously exhibited signs of diabetes but demonstrate elevated blood glucose levels during their gestational period. Diabetes mellitus, a metabolic disorder characterized by high blood sugar levels, has been observed to impact approximately 19% of pregnancies. This prevalence is believed to be increasing due to contemporary lifestyles that often involve excessive consumption of sugar, leading to the development of insulin resistance within the body. During pregnancy, regular visits are critical to ensure that the blood sugar is monitored. In addition, a healthy diet and supervised activity could be beneficial to both the baby and the mother. If not well managed, diabetes could be a cause for concern for both the baby and the mother during pregnancy, birth and later in life. In this paper, the aim is to gather more knowledge on why gestational diabetes disappears after birth and whether the child is at significant risk of developing diabetes in the latter stages of their life. This paper will demonstrate that the disappearance of gestational diabetes after childbirth raises concerns vis-à-vis the basic mechanisms through which this form of diabetes is developed and the potential long-term health implications for the mother and the baby regarding developing diabetes.
Maternal Diabetes and Offspring's Adiposity
Effects of Maternal Hyperglycemia on Fetal Growth and Development
Macrosomia (Large Birth Weight)
This is a condition characterized by an infant's excessive birth weight, associated with high levels of glucose in the mother's bloodstream and, consequently, gestational diabetes. Babies with this condition usually weigh more than 8 pounds and 13 ounces. Large birth weight occurs because the excess glucose available for the baby promotes excessive fetal growth. To this end, Lawlor et al. (2009) conducted research to determine whether there is a significant relationship between high glucose levels and increased birth weight. The authors found a significant correlation between elevated maternal glucose levels following a diabetes diagnosis and increased birth weight in addition to higher concentrations of C-peptide in the serum of the umbilical cord. In support of these findings, Metzger et al. (2008) documented that a rise in the 2-hour plasma glucose level increases the likelihood of a baby being born with a weight exceeding the 90th percentile by 1.38 times. As such, it can be concluded that Lawlor et al. (2009) and Metzger et al. (2008) provide compelling evidence supporting a consistent and strong association between maternal glucose levels below the diagnostic threshold for diabetes and increased birth weight, as well as elevated levels of C-peptide in the cord-blood serum.
Fetal Hyperinsulinemia
This is a condition causing multiple complications in fetal development and occurs when glucose passes through the placenta, increasing glucose concentration and resulting in fetal hyperinsulinemia (Hufnagel et al., 2022). As a result, a fetus with fetal hyperinsulinemia produces excess insulin in response to maternal hyperglycemia, which often leads to fetal overgrowth, macrosomia, and neonatal hypoglycemia. This is because maternal hyperglycemia induces fetal hyperinsulinemia, promoting adipose tissue accumulation and excessive fetal growth.
The consequences associated with weight gain during this particular period encompass a heightened susceptibility to retaining excess weight following caesarian sections, an increased likelihood of undergoing a caesarian section, a higher risk of postpartum obesity, an elevated probability of developing undesired diabetes and high blood pressure, adverse effects on fetal development, and an increased likelihood of preterm delivery. Among the aforementioned risks, diabetes poses the most significant adverse effects on both the fetus and the mother.
Risk of Birth Injuries
Birth injuries refer to damage occurring due to increased physical pressure during the birthing process. The risk of birth injuries escalates with larger infants, impacting the neonate and maternal figure during childbirth. According to Metzger et al. (2008), secondary outcomes of gestational diabetes include the occurrence of delivery before 37 weeks of gestation, the occurrence of shoulder dystocia or birth injury, the need for intensive neonatal care, the presence of hyperbilirubinemia, and the development of preeclampsia. However, Rowan et al. (2008) did not establish significant differences in these secondary outcomes between pregnant women with gestational diabetes and those without. This could be attributed to the interventions taken to minimize the birth injuries once a diagnosis has been made. Nonetheless, the increased risk of birth injuries in children born by pregnant women with gestational diabetes has been established. For example, research conducted by Kekki et al. (2022) indicates that the most common severe birth injury is brachial plexus, and the risk is highest in women with types 1 and 2 diabetes with 2.5% and 1.8% while those with gestational diabetes have a 0.5% risk compared to 0.3% in non-diabetic women. The risk, however, is insignificant.
Hypoglycemia in Newborns
This refers to lower-than-normal blood glucose levels. The risk for hypoglycemia in newborns is associated with having a diabetic parent, being born preterm and being smaller or larger than normal for a particular gestational age. Hypoglycemia in newborns results from the persistent production of elevated levels of insulin by their pancreas following childbirth. According to Lawlor et al. (2009), elevated levels of plasma glucose in both the mother and the fetus are correlated to the occurrence of primary cesarean delivery, clinical neonatal hypoglycemia, premature delivery, birth injury, preeclampsia, and hyperbilirubinemia.
Respiratory Distress Syndrome (RDS)
This is a common breathing disorder often affecting newborns before their due date, usually before seven months, but also in newborns, although this is uncommon. This is a major contributor to newborn morbidity and mortality. According to Atar et al. (2021), there is an association between infants of diabetic mothers (IDMs), including gestational diabetes and respiratory distress syndrome (RDS). This is associated with incomplete lung development in infants with macrosomia.
Neonatal Jaundice
Neonatal Jaundice, otherwise known as neonatal hyperbilirubinemia, comes from having elevated total serum bilirubin. This was addressed by Lawlor et al. (2009), who link elevated plasma glucose levels in both the mother and the fetus to hyperbilirubinemia. It is characterized by a discoloration of the skin, sclera, and mucous membrane.
Stillbirth and Congenital Anomalies
If healthcare providers fail to control maternal hyperglycemia, there is an increased risk of stillbirth and congenital anomalies. Based on research findings documented by Darbandi et al. (2021), mothers with gestational diabetes have a 1.8 times higher likelihood of stillbirth than the general population. Researchers link this finding with placental vascular pathology and changes in the fetal metabolic pathways.
Metabolic Programming
According to Chu and Godfrey (2020), an elevated glucose level can lead to developmental complications, often including type 2 diabetes, obesity resulting from eating disorders and metabolic syndrome all experienced at the latter stages of life.
Complications for the Mother
The effects of gestational diabetes are not limited to the infants. For the mothers, the condition leads to an increased risk of healthcare complications for the mother, such as preeclampsia, an elevated likelihood of cesarean section, and gestational hypertension. By extension, mothers are faced with damage to the kidneys and other vital organs. In addition, the increased baby size necessitates a cesarean delivery, which is associated with risks of infection, bleeding, and injury to the mother and the baby.
Management and Prevention
To mitigate these risks, one must first confirm the diagnosis. In the literature, there are several fetal tests available to assess fetal activity during mid-pregnancy. First, during the initial 11 weeks of gestation, one can use various diagnostic assessment tools, which include the biophysical profile, nonstress test (NST), and evaluation of arterial-wave-form velocities to ascertain the presence of any potential complications pertaining to fetal development. While it is acknowledged that utilizing certain methodologies is time-intensive, these tools have proven valuable in elucidating issues pertaining to fetal development and facilitating informed decision-making throughout pregnancy. The success of these experiments is primarily attributed to the fetal responses to external stimuli, particularly sound. The following methods can be used to manage and prevent the effects of gestational diabetes on the infant.
First, controlling the blood sugar. One can use a blood sugar testing kit to monitor their blood sugar and follow appropriate treatment plans, preventing adverse outcomes for the mother and the baby (Hedderson et al., 2010). Second, one can modify one's diet and increase supervised physical activity (Hedderson et al., 2010). This helps by controlling blood sugar and reducing excessive weight gain during pregnancy. The key is optimizing one’s caloric intake to one's level of exercise (Hedderson et al., 2010). In addition, medication can be used to manage blood sugar of exercise is insufficient. Two options, i.e., metformin and insulin, have been tested, and their effectiveness is documented by Rowan et al. (2008). According to Rowan et al. (2008), the utilization of metformin as a potential therapeutic approach for women diagnosed with gestational diabetes mellitus appears to be a rational choice.
Rowan et al. (2008) observed that the speed of the primary composite outcome was 32.0% in the group of women assigned to metformin and 32.2% in the insulin group. Further, a majority of women who were administered metformin injections expressed a preference for this treatment over insulin. In addition, 46.3% of these women required supplemental insulin in conjunction with metformin during the course of their treatment. Conversely, the participants expressed a strong inclination towards receiving the identical intervention during their subsequent pregnancies, with a significant difference observed between the two groups (76.6% vs. 27.2%). It is noteworthy that metformin exhibited a favorable safety profile, with no significant occurrence of serious adverse effects. Nevertheless, the comparative analysis of treatment acceptance rates between the two groups, namely those administered metformin and those administered insulin, revealed minimal differences.
Maternal Diabetes and Offspring's Pregnancy Outcomes
Maternal diabetes significantly impacts the delivery process and necessitates specialized neonatal care to address potential complications. First, the elevated blood glucose and resulting larger infants pose challenges during delivery, potentially leading to birth injuries for both the neonate and the mother. Second, infants born to mothers with higher blood sugar levels are prone to suffer from hypoglycemia in the immediate postnatal period. This is the result of continued production of elevated insulin levels, by the infants’ pancreas. Suffice it to say that the offspring, therefore, needs specialized care to save their life. Third, infants born to diabetic mothers are more prone to respiratory distress syndrome, which is a heightened risk associated with incomplete lung development. This means that, once again, the child requires specialized neonatal care to address respiratory complications, which could lead to post-natal mortality. Fourth, the bilirubin levels in the blood must be monitored because they inform on the potentiality of liver failure. In addition, there is a need for meticulous neonatal care for early detection and intervention of post-natal concerns such as jaundice, and in order to address the infant's susceptibility to obesity, type 2 diabetes, and metabolic syndrome, emphasize the need for specialized strategies in neonatal care.
Improving Outcomes
Research by Hedderson et al. (2010) demonstrates that the consequences associated with prenatal weight gain lead to increased vulnerability to retaining excess weight after undergoing caesarian sections. In addition, there is a risk of an increased likelihood of undergoing the caesarian section, a higher risk of postpartum obesity, an elevated probability of developing undesired diabetes and high blood pressure, adverse effects on fetal development, and an increased likelihood of preterm delivery. Among the aforementioned risks, diabetes poses the most significant adverse effects on both the fetus and the mother.
Research conducted by Landon et al. (2009) supports the assertion that better care improves patient outcomes. In this study, Landon et al. (2009) aimed to identify the clinical measure that offers the highest cost-effectiveness in screening for gestational diabetes. The concept of cost-effectiveness pertains to the evaluation of risk factors associated with various methodologies. The utilization of a two-stage screening approach is commonly employed in the assessment of glucose tolerance. This method involves the implementation of both the glucose challenge test and the oral glucose tolerance test. Additionally, the universal oral glucose tolerance test with or without fasting is also frequently utilized in this context. No instances of fetal mortality were observed during the prenatal period. A notable decrease in various secondary outcomes was observed when the treatment was administered compared to the usual care.
In the study, Landon et al. (2009) discovered that the treatment of gestational diabetes mellitus was associated with reduced rates of preeclampsia and gestational hypertension when compared to standard care. The combined rates for these two conditions were found to be 8.6% in the treatment group, compared to 13.6% in the control group. The efficacy of treatment for mild gestational diabetes mellitus in relation to reducing the occurrence of composite outcomes, such as stillbirths, prenatal deaths, and neonatal complications, is not significantly evident. However, it does demonstrate a reduction in the risk of certain complications, including fetal overgrowth, shoulder dystocia, cesarean delivery, and hypertensive disorders.
Challenges and Recommendations for Improving the Quality of Care for Diabetic Mothers and Their Offspring
Challenges
For this group, the challenges to be overcome in order to improve the quality of care for diabetic mothers and their offspring are as follows. First, controlling the blood sugar. Achieving and maintaining optimal glycemic control throughout pregnancy is a significant challenge because fluctuations in blood glucose levels can contribute to adverse outcomes for both the mother and the neonate. Second, neonatal monitoring and patient adherence. While intensive monitoring of the neonates is essential, it is logistically and financially challenging. The patients, therefore, might face challenges in adhering to the prescribed management plans, including intensive monitoring, dietary modifications, regular exercise, and medication adherence. Finally, the level of care described herein requires a multidisciplinary approach, which might be hard to achieve. At the very least, a diabetic mother will need a physiotherapist, an endocrinologist, a dietitian, a pediatrician, and a cardiologist. This interdisciplinary approach can be challenging due to the need for seamless communication and collaboration.
Recommendations
Several recommendations can be made to address these challenges. First, the mother can be encouraged to be proactive in optimizing their blood sugar levels before pregnancy. This should be combined with patient education and support to enable them to make more informed choices, even in terms of diet and activity. Second, multidisciplinary teams can be made to care for this population. This enhances collaboration among healthcare professionals, boosting the outcome because clear communication pathways and a unified care plan ensure holistic support for diabetic mothers and their offspring. Finally, community outreach and neonatal care protocols can be established to optimize access to care and minimize waste.
Maternal Diabetes and Offspring's Risk of Diabetes
Maternal Diabetes Effect on Offspring’s Immune System and Genetic MakeUp
Maternal diabetes during pregnancy affects the immune system and genetic composition. This happens because exposure to elevated blood sugar levels could affect regulatory mechanisms that govern immune responses. These changes can contribute to an increased risk of autoimmune responses, including those associated with the development of diabetes. In addition, epigenetic modifications, such as DNA methylation and histone acetylation, can be altered by the intrauterine environment shaped by maternal diabetes. This impacts gene expression patterns relevant to glucose metabolism, insulin sensitivity, and the regulation of pancreatic function, ultimately influencing the risk of diabetes in the offspring. Thus, maternal diabetes has the potential to exert an influence on the infant's genetic profile and immune system, affecting their well-being.
According to research by Blotsky et al. (2019), the incidence of pediatric diabetes per ten thousand person-years is higher (4.52) in children born to mothers with gestational diabetes than in the general population (2.4). When all factors are adjusted, Blotsky et al. (2019) establish that maternal gestational diabetes is associated with the development of pediatric diabetes. Another research by Wang et al. (2020) supports these findings and adds that feeding and eating disorders in offspring are also positively associated with being born to a mother with gestational diabetes. Based on the study, the incidence rate for feeding and eating disorders is higher (6.8) per ten thousand person-years in infants born to a mother with gestational diabetes than in the general population (2.9). This directly relates to obesity.
Causes of Gestational Diabetes and Preventive Measures
Causes
Hormonal Fluctuations During Pregnancy
Pregnancy hormones could interfere with insulin, a hormone responsible for regulating the blood sugar level. In this case, the mother's body experiences a deficiency in insulin production. This deficiency is attributed to the body utilizing the available insulin to support pregnancy, resulting in a depletion of insulin levels (Choudhury & Rajeswari, 2021). Consequently, this depletion leads to a condition known as hyperglycemia, characterized by abnormally elevated levels of glucose in the bloodstream. In addition, as established by Retnakaran et al. (2010), women with gestational diabetes have a declining β-cell function in the 1st year postpartum. According to Choudhury and Rajeswari (2021), this leads to hyperglycemia because β-cell assists in balancing the demand for and supply of insulin.
Obesity
The phenomenon of pregnancy obesity has been found to exhibit a strong correlation with an elevated risk factor during pregnancy. The correlation between gestational pregnancy and its implications on public health underscores the gravity of this matter. It is imperative to acknowledge the occurrence of adverse pregnancy outcomes, such as gestational diabetes mellitus, gestational hypertension, fetal macrosomia, and various other complications. Women with an elevated body mass index face an increased susceptibility to the development of gestational diabetes mellitus. The observed outcomes of this phenomenon are associated with the development of disorders in the fetus. Gestational obesity has emerged as a significant concern in recent years.
The consequences associated with weight gain during this particular period encompass a heightened susceptibility to retaining excess weight following caesarian sections, an increased likelihood of undergoing a caesarian section, a higher risk of postpartum obesity, an elevated probability of developing undesired diabetes and high blood pressure, adverse effects on fetal development, and an increased likelihood of preterm delivery. Among the aforementioned risks, diabetes poses the most significant adverse effects on both the fetus and the mother.
Age
An increase in maternal age is associated with an increase in gestational diabetes. According to Li et al. (2020), the incidence of gestational diabetes is higher in older patients, with the conventional knowledge capping the age at 25 years. However, Li et al. (2020) establish an interaction between the pre-pregnancy BMI and age regarding gestational diabetes. The risk is most significant when the one is between 30 and 34 years old with a pre-pregnancy BMI of 30 kg/m2.
Ethnicity
Women who cannot be classified as Anglo-European descent are at a higher risk of developing gestational diabetes mellitus. These include African-American, Hispanic, and Asian American women.
Familial History of Diabetes
As mentioned earlier, gestational diabetes is characterized by a declining β-cell function, which is common in other diabetic patients. Since a family of diabetes increases the chances of having prediabetes, gestational diabetes becomes common.
Preventive Measures
First, community outreach and creation of awareness about the importance of health consciousness for the child and the parent, focusing on a balanced diet, optimal caloric intake and optimal exercise. Second, regular monitoring. The mother should avail herself and the child for regular checks to determine the blood sugar levels, enhancing proactivity in addressing diabetes. Third, genetic counseling can be adopted to evaluate the potential risk of the child and design the necessary intervention measures before the child becomes diabetic. Fourth, the child and the parents could be educated on their role regarding exercise, healthy lifestyle and diabetes hazards. Finally, mothers should breastfeed when feasible because it is associated with a reduced risk of type 2 diabetes.
Conclusion
In conclusion, gestational diabetes mellitus has increased in prevalence in recent decades, and its disappearance during birth poses questions about the underlying mechanisms involved as well as the potential long-term health implications for both the mother and the baby, particularly the risk of developing diabetes later in life. This paper finds that maternal diabetes is associated with increased birth weight, fetal hyperinsulinemia, increased risk for birth injuries, especially shoulder dystocia, hypoglycemia, respiratory distress syndrome, neonatal jaundice, stillbirth, and maladaptive metabolic programming, not to mention the complications to the mother. This can be managed by controlling blood sugar through exercise, dieting and medication. Further, during and after delivery, the mother and neonate require close monitoring due to the risk mentioned. However, fluctuations in hormone levels during pregnancy, poor adherence to treatment plans and lack of collaboration might hamper these efforts. If not well managed, the offspring’s immune system and genetic makeup are often affected, leaving them vulnerable to diabetes, feeding and eating disorders and obesity. Gestational diabetes mellitus can be addressed by addressing pre-pregnancy obesity and hormonal fluctuations.
References
Atar, H. Y., Baatz, J. E., & Ryan, R. M. (2021). Molecular mechanisms of maternal diabetes Effects on fetal and neonatal surfactant. Children (Basel), 8(4), 281. https://doi.org/10.3390/children8040281
Blotsky, A., Rahme, E., Dahhou, M., Nakhla, M., & Dasgupta, K. (2019). Gestational diabetes associated with incident diabetes in childhood and youth: a retrospective cohort study. Canadian Medical Association Journal, 191(15), E410–E417. https://doi.org/10.1503/cmaj.181001
Choudhury, A. A., & Rajeswari, V. D. (2021). Gestational diabetes mellitus - A metabolic and reproductive disorder. Biomedicine & Pharmacotherapy, 143, 112183. https://doi.org/10.1016/j.biopha.2021.112183
Chu, A. H. Y., & Godfrey, K. M. (2020). Gestational diabetes mellitus and developmental programming. Annals of Nutrition and Metabolism, 76(Suppl. 3), 4–15. https://doi.org/10.1159/000509902
Darbandi, M., Rezaeian, S., Dianatinasab, M., Yaghoobi, H., Soltani, M., Etemad, K., Valadbeigi, T., Taherpour, N., Hajipour, M., & Sedaghat, R. (2021). Prevalence of gestational diabetes and its association with stillbirth, preterm birth, macrosomia, abortion and cesarean delivery: a national prevalence study of 11 provinces in Iran. PubMed, 62(4), E885–E891. https://doi.org/10.15167/2421-4248/jpmh2021.62.4.1788
Hedderson, M. M., Gunderson, E. P., & Ferrara, A. (2010). Gestational weight gain and risk of gestational diabetes mellitus. Obstetrics & Gynecology, 115(3), 597–604. https://doi.org/10.1097/aog.0b013e3181cfce4f
Hufnagel, A., Dearden, L., Fernandez‐Twinn, D. S., & Ozanne, S. E. (2022). Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia. Journal of Endocrinology, 253(2), R47–R63. https://doi.org/10.1530/joe-21-0332
Kekki, M., Tihtonen, K., Salonen, A., Koukkula, T., Gissler, M., Laivuori, H., & Huttunen, T. T. (2022). Severe birth injuries in neonates and associated risk factors for injury in mothers with different types of diabetes in Finland. International Journal of Gynecology & Obstetrics, 159(1), 195–203. https://doi.org/10.1002/ijgo.14073
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B. M., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., Sciscione, A., Catalano, P. M., Harper, M., Saade, G. R., Lain, K., Sorokin, Y., Peaceman, A. M., Tolosa, J. E., & Anderson, G. (2009). A multicenter, randomized trial of treatment for mild gestational diabetes. The New England Journal of Medicine, 361(14), 1339–1348. https://doi.org/10.1056/nejmoa0902430
Lawlor, D. A., Fraser, A., Lindsay, R., Ness, A. R., Dabelea, D., Catalano, P. M., Smith, G. D., Sattar, N., & Nelson, S. M. (2009). Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia, 53(1), 89–97. https://doi.org/10.1007/s00125-009-1560-z
Li, G., Tao, W., Ni, W., Ai, Z., Zhang, J., Xing, Y., & Xing, Q. (2020). Incidence and risk factors of gestational diabetes mellitus: a prospective cohort study in Qingdao, China. Frontiers in Endocrinology, 11. https://doi.org/10.3389/fendo.2020.00636
Metzger, B. E., Lowe, L. P., Dyer, A. R., Trimble, E. R., Chaovarindr, U., Coustan, D. R., Hadden, D. R., McCance, D. R., Hod, M., McIntyre, H. D., Oats, J., Persson, B., Rogers, M. S., & Sacks, D. A. (2008). Hyperglycemia and adverse pregnancy outcomes. The New England Journal of Medicine, 358(19), 1991–2002. https://doi.org/10.1056/nejmoa0707943
Retnakaran, R., Qi, Y., Sermer, M., Connelly, P. W., Hanley, A. J., & Zinman, B. (2010). Β-Cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy. Diabetes Care, 33(8), 1798–1804. https://doi.org/10.2337/dc10-0351
Rowan, J., Hague, W., Gao, W., Battin, M., & Moore, M. C. (2008). Metformin versus Insulin for the Treatment of Gestational Diabetes. The New England Journal of Medicine, 358(19), 2003–2015. https://doi.org/10.1056/nejmoa0707193
Wang, H., He, H., Yu, Y., Su, X., Li, F., & Li, J. (2020). Maternal diabetes and the risk of feeding and eating disorders in offspring: a national population-based cohort study. BMJ Open Diabetes Research & Care, 8(1), e001738. https://doi.org/10.1136/bmjdrc-2020-001738